Severe recalcitrant erythematous desquamating disorder associated with fatal recurrent toxic shock syndrome in a patient without AIDS

Clinical Infectious Diseases

Volumn 24, Issue 6, 1997, Pages 1274-1275

  Verbon, Annelies ^a   Fisher Jr , Charles J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; RIFAMPICIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DESQUAMATION; DISEASE ASSOCIATION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; SKIN MANIFESTATION; TOXIC SHOCK SYNDROME;

EID: 0030962245     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.6.1274     Document Type: Article

References (6)

1. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group I staphylococci. Lancet 1978;2:1116-8.
2. Fisher CJ, Horowitz BZ, Nolan SM. The clinical spectrum of toxic shock syndrome. West J Med 1981; 135:175-82.
3. Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM. The disease spectrum, epidemiology, and etiology of toxic-shock syndrome. Annu Rev Microbiol 1984;38:315-38.
4. Cone LA, Woodard DR, Byrd RG, Schulz K, Kopp SM, Schlievert PM. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992; 165:638-43.
5. Garbe PL, Arko RJ, Reingold AL, et al. S. aureus isolates from patients with nonmenstrual shock syndrome. Evidence for additional toxins. JAMA 1985;253:2538-42.
6. Deetz TR, Reves R, Septimus E. Secondary rash in toxic-shock syndrome [letter]. N Engl J Med 1981;304:174.